Clinical-stage biotech developing cancer immunotherapies.
Industry: Health Care
First Day Return: +13.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/16/2018 |
Offer Price | $15.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 8.0 |
Deal Size ($mm) | $120 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/14/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $120 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Hayward, CA, United States |
Founded | 2015 |
Employees at IPO | 83 |
Website www.arcusbio.com |